Results 71 to 80 of about 11,355 (206)

Research Progress on Risk Factors and Prognosis of Masked Uncontrolled Hypertension [PDF]

Advances in Clinical Medicine
君寅 方
openalex   +2 more sources

Association of hyperuricemia and hypertension phenotypes in hypertensive patients without uric acid lowering treatment

Clinical and Experimental Hypertension, 2021
Background Current study was to evaluate the association of hypertensive and hypertension phenotypes in hypertensive populations. Methods Patients with primary hypertension and without any uric acid (UA)-lowering treatment were enrolled.
Chunying Liu, Da Qiu, Min Zhang, Jue Hou, Jinye Lin, Huocheng Liao   +5 more
doaj   +1 more source

Correlation between masked hypertension and endothelial dysfunction measured by flow-mediated dilation: a protocol of systematic review and meta-analysis

BMJ Open, 2021
Introduction A surrogate marker to evaluate artery endothelial response when stimulated by reactive hyperaemia, known as brachial flow-mediated dilation (FMD), has prognostic value in predicting hypertensive organ damage and cardiovascular disease events.
Yong Li, Xiaohua Zhang, Ling Gao, Qian Yu, Congliang Zhou, Wenshu Zou   +5 more
doaj   +1 more source

Arterial stiffness and its relationship to clinic and ambulatory blood pressure: a longitudinal study in non-dialysis chronic kidney disease [PDF]

, 2016
Background Both arterial stiffness and systolic blood pressure (BP) are established cardiovascular risk factors, yet little is known about their interrelationship in chronic kidney disease (CKD).
Agarwal, Rajiv
core   +1 more source

Autonomic dysfunction, cardio-pulmonary parameters and masked heart failure in non-severe  chronic obstructive pulmonary disease [PDF]

Българска кардиология, 2020
Background: Autonomic dysfunction (AD) and cardio-pulmonary exercise testing (CPET) parameters have been associated with masked heart failure with preserved ejection fraction (HFpEF) in the general population.
Zheina Cherneva, Radostina Cherneva
doaj   +3 more sources

Proteomic-biostatistic integrated approach for finding the underlying molecular determinants of hypertension in human plasma [PDF]

, 2017
Despite advancements in lowering blood pressure, the best approach to lower it remains controversial because of the lack of information on the molecular basis of hypertension.
Biessen, Erik, Bilo, Grzegorz, Delles, Christian, Floege, Juergen, Gajjala, Prathibha R., Heinze, Georg, Jankowski, Joachim, Jankowski, Vera, Kawecka-Jaszcz, Kalina, Kork, Felix, Liehn, Elisa, Narkiewicz, Krzysztof, Noels, Heidi, Perco, Paul, Schulz, Anna, Soranna, Davide, Zanchetti, Alberto, Zidek, Walter   +17 more
core   +1 more source

Masked nocturnal hypertension as a result of high prevalence of non-dippers among apparently well-controlled hypertensive patients with type 2 diabetes mellitus: data from a prospective study

Diabetology & Metabolic Syndrome, 2022
Background Ambulatory blood pressure monitoring (ABPM) in patients with diabetes mellitus (DM) and hypertension (HTN) show the dipping patterns, identify masked uncontrolled hypertension (MUCH), and demonstrate the effectiveness of the blood pressure (BP)
Pop Călin, Manea Viorel, Pruna Luchiana, Cosma Mihaela, Pop Lavinia   +4 more
doaj   +1 more source

Clinical and Prognostic Value of Exaggerated Blood Pressure Response to Exercise

Reviews in Cardiovascular Medicine, 2023
The hypertensive response to exercise testing, defined as exaggerated blood pressure response (EBPR), has been documented to be independently associated with unhealthy conditions, carrying an increased risk of future hypertension, cardiovascular (CV ...
Cesare Cuspidi, Andrea Faggiano, Elisa Gherbesi, Carla Sala, Guido Grassi, Marijana Tadic   +5 more
doaj   +1 more source

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. [PDF]

, 2014
BACKGROUND: Proliferative diabetic retinopathy (PDR) is a complication of diabetic retinopathy that can cause blindness. Although panretinal photocoagulation (PRP) is the treatment of choice for PDR, it has secondary effects that can affect vision.
Buil-Calvo, José A, Cordero, Josep A, Evans, Jennifer R, Martinez-Zapata, Maria José, Martí-Carvajal, Arturo J, Pijoán, José I, Solà, Ivan   +6 more
core   +2 more sources

Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications [PDF]

, 2019
Background: Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Diabetes mellitus (DM) has been reported to be a risk factor in patients with GO.
Biondi, B, Liccardi, A, Peschi, L, Pontieri, G, Ruggiero, A R, Urselli, F   +5 more
core   +2 more sources